A clinical trial will test whether partial prostate ablation matches radical prostatectomy in effectiveness — with fewer early side effects. Destroying part of the prostate to treat prostate ...

The impact of partial brachytherapy on metastasis and disease-specific mortality is unclear. Partial prostate treatment with MRI-guided brachytherapy may lead to poor outcomes long-term among patients ...

Regulation of the tumor suppressor PLZF and prostate cancer prognosis. This is an ASCO Meeting Abstract from the 2018 Genitourinary Cancers Symposium. This abstract does not include a full text ...

Vascular-targeted photodynamic therapy continues to shows efficacy for partial gland ablation of intermediate-risk prostate cancer with minimal toxicity, according to long-term follow-up results from ...

Prostate cancer is a disease in which malignant (cancer) cells form in the tissues of the prostate gland. In most men, prostate disease grows very slowly. The majority of men with low-grade, early ...

Immune response with sipuleucel-T in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Phase II ProACT study. Concurrent treatment with everolimus (RAD001) and ...

CURE spoke with David Albala, M.D., about the impact robotic surgery has had on patients with prostae cancer. For patients with prostate cancer who are undergoing a prostatectomy, robotic surgery has ...